VolitionRX Ltd
VNRX
Market Cap$81.33M
Close$
$1.02
104% upside
Current Fair Value
104% upsideUndervalued by 104% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $81.33 Million |
|---|---|
| Enterprise Value | $84.11 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-0.5 |
| Beta | 1.1 |
| Outstanding Shares | 82,669,335 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -2.25 |
|---|---|
| PEG | 7.39 |
| Price to Sales | - |
| Price to Book Ratio | -0.5 |
| Enterprise Value to Revenue | 65.41 |
| Enterprise Value to EBIT | -3.49 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.07 |
| Debt to Equity | -0.24 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About VolitionRX Ltd
65 employeesVolition is a multi-national epigenetics company developing simple, easy to use, costeffective blood tests to help diagnose a range of cancers and other diseases. Early diagnosis has the potential to not only prolong the life of patients...